HIGHLIGHTS
- What: The authors present the results of the second primary objective of the trial, which aimed to compare the costs of the patient-centred monitoring approach versus standard monitoring. The analysis presented was in the intention-to-treat population set, including all randomised participants. The study was designed to demonstrate the non-inferiority of a dual treatment regimen, with multiple HIV-RNA measurements for all participants.
- Who: Annalisa Marinoscia et al. from the Geneva University of Medicine, Geneva, Switzerland have published the research: Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.